United Therapeutics Corporation

Form 483 issued May 2, 2024 · Silver Spring, Maryland

Inspection
Apr 22 – May 2, 2024
Observations
3
Pages
4
FEI number
3003368324

In short: On May 2, 2024, FDA issued a Form 483 with 3 observations to United Therapeutics Corporation in Silver Spring, Maryland (FEI 3003368324) after an inspection that ran Apr 22 – May 2, 2024. The investigators were Annet R. Rajan, Janet A. Rajan and Mindy M. Chou. Most observations concern production and quality system.

At a glance

Production and quality system account for 2 of 3 observations.

Production1
Quality system1
Materials1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are…

  2. 02

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  3. 03

    Reports of analysis from component suppliers are accepted in lieu of testing each component for conformity…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at United Therapeutics Corporation?

FDA listed 3 observations on this Form 483, mostly about production, quality system and materials. The opening words of each observation are shown on this page.

Who inspected United Therapeutics Corporation?

Annet R. Rajan, Janet A. Rajan and Mindy M. Chou are named on this Form 483, for the inspection of Apr 22 – May 2, 2024. Each investigator has a profile showing what they cite most.

When was United Therapeutics Corporation inspected by FDA?

The inspection ran Apr 22 – May 2, 2024, and the Form 483 is dated May 2, 2024.

How do I get the full Form 483 for United Therapeutics Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free